(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-0.15%) $82.51
(0.54%) $2.04
(-0.58%) $2 344.10
(-1.08%) $27.36
(0.02%) $961.70
(0.12%) $0.934
(0.18%) $11.00
(0.05%) $0.796
(0.01%) $93.31
9.90% $ 0.751
Live Chart Being Loaded With Signals
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma...
Stats | |
---|---|
Volumen de hoy | 275 028 |
Volumen promedio | 174 998 |
Capitalización de mercado | 36.22M |
EPS | $-0.250 ( 2024-03-26 ) |
Próxima fecha de ganancias | ( $-0.270 ) 2024-06-20 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.600 |
ATR14 | $0.00500 (0.67%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-22 | White Debra | Buy | 150 000 | Employee stock option (right to buy) |
2024-02-22 | Sparks Ronald M | Buy | 150 000 | Employee stock option (right to buy) |
2024-02-22 | Lapidus Stanley | Buy | 150 000 | Employee stock option (right to buy) |
2024-02-22 | Cox James L | Buy | 150 000 | Employee stock option (right to buy) |
2024-02-22 | Sokolov Jacque J | Buy | 150 000 | Employee stock option (right to buy) |
INSIDER POWER |
---|
33.30 |
Last 57 transactions |
Buy: 13 183 319 | Sell: 4 158 892 |
Volumen Correlación
Lucid Diagnostics Inc. Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Lucid Diagnostics Inc. Correlación - Moneda/Commodity
Lucid Diagnostics Inc. Finanzas
Annual | 2023 |
Ingresos: | $2.43M |
Beneficio Bruto: | $-6.05M (-249.18 %) |
EPS: | $-1.260 |
FY | 2023 |
Ingresos: | $2.43M |
Beneficio Bruto: | $-6.05M (-249.18 %) |
EPS: | $-1.260 |
FY | 2022 |
Ingresos: | $377 000 |
Beneficio Bruto: | $-3.24M (-858.62 %) |
EPS: | $-1.550 |
FY | 2021 |
Ingresos: | $500 000 |
Beneficio Bruto: | $-85 000.00 (-17.00 %) |
EPS: | $-1.510 |
Financial Reports:
No articles found.
Lucid Diagnostics Inc.
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its lead products include EsoGuard, a laboratory developed esophageal DNA test; and EsoCheck, an esophageal cell collection device. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico